Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AACR, acknowledged, Alpine, aplastic, benchmarking, bleeding, CASI, Century, CEO, CFO, cira, classed, contemplated, cyclophosphamide, deployment, derecognized, FujiFilm, harbor, highest, highlighted, immunomodulatory, implicit, ischemic, Japan, Linea, Lunger, lymphodepleting, lymphodepletion, MHLW, Minerva, neurologic, OncoSec, prioritization, prolonged, readily, reassessed, resubmission, RIND, Rx, Servier, stagger, straight, stroke, succeed, TIA, transmembrane, unamortized, undue, uneven, Unum
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view